Cargando…

Docetaxel-Induced Stevens-Johnson Syndrome in a Patient with Metastatic Prostate Adenocarcinoma

Docetaxel is a commonly used chemotherapeutic agent in a variety of cancer treatment regimens. We present a case of apparent docetaxel-induced Stevens-Johnson syndrome (SJS) in a patient recently treated for metastatic prostate cancer. This medication is not classically associated with the developme...

Descripción completa

Detalles Bibliográficos
Autores principales: Diab, Osama, Mcentire, Dan, Kassim, Thamer, Nayfeh, Ali, Dajani, Abdel Rahman, Kerfeld, Mitchell, Campbell, Jonathon, Alsuwaidan, Adbullah, Hazeem, Mahmoud Abu, Gbadamosi-Akindele, Maryam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341237/
https://www.ncbi.nlm.nih.gov/pubmed/30729055
http://dx.doi.org/10.1155/2019/7928752
Descripción
Sumario:Docetaxel is a commonly used chemotherapeutic agent in a variety of cancer treatment regimens. We present a case of apparent docetaxel-induced Stevens-Johnson syndrome (SJS) in a patient recently treated for metastatic prostate cancer. This medication is not classically associated with the development of SJS but in our case, along with a number of other case reports, and a single phase II clinical trial, an association was recognized. We encourage clinicians who employ the use of this medication to be aware of this relationship.